• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SOS-SAH 问卷在临床实践中的应用:一项多方法评估研究。

The SOS-SAH questionnaire in clinical practice: a multi-method evaluation study.

机构信息

Department of Neurology, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands.

Department of Neurosurgery, Radboud University Medical Center, Nijmegen, the Netherlands.

出版信息

BMC Neurol. 2023 Jun 19;23(1):236. doi: 10.1186/s12883-023-03280-w.

DOI:10.1186/s12883-023-03280-w
PMID:37337139
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10280905/
Abstract

BACKGROUND

In patients with mild disabilities after aneurysmal subarachnoid hemorrhage (aSAH), invisible symptoms might be easily overlooked during consultations in the outpatient clinic. We hypothesize that the Questionnaire for the Screening of Symptoms in aneurysmal Subarachnoid Hemorrhage (SOS-SAH), a disease-specific patient-reported outcome measure, might aid in screening for symptoms after aSAH. The objective of this explorative study is to evaluate the perceived impact of using the SOS-SAH in daily clinical practice for patients after aSAH, as well as to explore potential barriers to further implementation.

METHODS

This multi-method study consists of a quantitative and a qualitative component. To evaluate differences in quality of care, a patient experience survey was sent to patients receiving usual care and to patients who received the SOS-SAH. A multiple linear regression model was applied, with the intervention group and case mix adjusters as independent variables. We described differences in the number of symptoms discussed between patients receiving usual care and those receiving care post-implementation. Following implementation, 16 patients and 6 healthcare professionals were interviewed about their perceptions concerning the impact of and barriers to using the SOS-SAH. A thematic analysis was performed to identify the main themes.

RESULTS

The survey did not reveal any differences between the usual-care group and the post-implementation group on the scales of the patient experience survey. After implementation of the SOS-SAH, the number of symptoms discussed during consultation did not increase. The interviews suggest that the SOS-SAH may improve the preparation of patients by providing them with greater insight into their complaints and by raising issues for the consultation. It could also enhance the structure and efficiency of consultation, in addition to improving communication about issues that matter to patients. All patients and healthcare professionals recommended continuing the use of the SOS-SAH in daily practice.

CONCLUSIONS

Although no quantitative improvements were found in patient experience and symptoms discussed during consultation, implementation of the SOS-SAH could aid in screening for symptoms in patients after aSAH, and it might have a positive influence on patient preparation, while helping to structure consultations between patients and healthcare professionals.

摘要

背景

在患有轻度残疾的动脉瘤性蛛网膜下腔出血(aSAH)患者中,门诊就诊时可能很容易忽略那些隐形症状。我们假设,专门用于筛查动脉瘤性蛛网膜下腔出血症状的患者报告结局测量工具——症状筛查问卷(SOS-SAH),可能有助于筛查 aSAH 后的症状。本探索性研究的目的是评估在 aSAH 后患者的日常临床实践中使用 SOS-SAH 的感知影响,以及探索进一步实施的潜在障碍。

方法

本多方法研究包括定量和定性两个部分。为了评估护理质量的差异,向接受常规护理的患者和接受 SOS-SAH 的患者发送了患者体验调查。应用多元线性回归模型,将干预组和病例组合调整器作为自变量。我们描述了接受常规护理的患者和接受实施后护理的患者之间讨论的症状数量的差异。在实施后,对 16 名患者和 6 名医护人员进行了关于他们对使用 SOS-SAH 的影响和障碍的看法的访谈。进行了主题分析以确定主要主题。

结果

调查未显示常规护理组和实施后组在患者体验调查量表上的任何差异。在实施 SOS-SAH 后,咨询期间讨论的症状数量并未增加。访谈表明,SOS-SAH 通过使患者更深入地了解自己的投诉并提出咨询问题,从而可能改善患者的准备情况。它还可以增强咨询的结构和效率,同时改善与患者相关的问题的沟通。所有患者和医护人员都建议在日常实践中继续使用 SOS-SAH。

结论

尽管在患者体验和咨询期间讨论的症状方面未发现定量改善,但实施 SOS-SAH 可能有助于筛查 aSAH 后的症状,并且可能对患者准备产生积极影响,同时帮助患者与医护人员之间的咨询结构。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/261b/10280905/5912d59ea1d6/12883_2023_3280_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/261b/10280905/5912d59ea1d6/12883_2023_3280_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/261b/10280905/5912d59ea1d6/12883_2023_3280_Fig1_HTML.jpg

相似文献

1
The SOS-SAH questionnaire in clinical practice: a multi-method evaluation study.SOS-SAH 问卷在临床实践中的应用:一项多方法评估研究。
BMC Neurol. 2023 Jun 19;23(1):236. doi: 10.1186/s12883-023-03280-w.
2
Development of a patient-reported outcome measure for patients who have recovered from a subarachnoid hemorrhage: the "questionnaire for the screening of symptoms in aneurysmal subarachnoid hemorrhage" (SOS-SAH).开发一种用于蛛网膜下腔出血后康复患者的患者报告结局测量工具:“动脉瘤性蛛网膜下腔出血症状筛查问卷”(SOS-SAH)。
BMC Neurol. 2021 Apr 16;21(1):162. doi: 10.1186/s12883-021-02184-x.
3
Elevated Systemic IL-6 Levels in Patients with Aneurysmal Subarachnoid Hemorrhage Is an Unspecific Marker for Post-SAH Complications.颅内动脉瘤性蛛网膜下腔出血患者的系统性白细胞介素-6 水平升高是蛛网膜下腔出血后并发症的非特异性标志物。
Int J Mol Sci. 2017 Dec 1;18(12):2580. doi: 10.3390/ijms18122580.
4
Differentiating reversible cerebral vasoconstriction syndrome with subarachnoid hemorrhage from other causes of subarachnoid hemorrhage.区分蛛网膜下腔出血中的可逆性脑血管收缩综合征与其他蛛网膜下腔出血病因。
JAMA Neurol. 2013 Oct;70(10):1254-60. doi: 10.1001/jamaneurol.2013.3484.
5
Long-term Course of Cognitive Functioning After Aneurysmal and Angiographically Negative Subarachnoid Hemorrhage.颅内动脉瘤性和血管造影阴性蛛网膜下腔出血后认知功能的长期病程。
Neurosurgery. 2023 Dec 1;93(6):1235-1243. doi: 10.1227/neu.0000000000002559. Epub 2023 Jun 5.
6
Long-term reintegration and quality of life in patients with subarachnoid hemorrhage and a good neurological outcome: findings after more than 20 years.长期再融入和良好神经功能结局的蛛网膜下腔出血患者的生活质量:20 多年后的发现。
J Neurosurg. 2018 Mar;128(3):785-792. doi: 10.3171/2016.11.JNS16805. Epub 2017 Apr 28.
7
Restrictions and satisfaction with participation in patients who are ADL-independent after an aneurysmal subarachnoid hemorrhage.动脉瘤性蛛网膜下腔出血后日常生活活动能力独立的患者参与研究的限制与满意度
Top Stroke Rehabil. 2017 Mar;24(2):134-141. doi: 10.1080/10749357.2016.1194557. Epub 2016 Jun 20.
8
Health-Related Quality-of-Life Outcomes: Comparing Patients With Aneurysmal and Nonaneurysmal Subarachnoid Hemorrhage.健康相关生活质量结果:比较动脉瘤性和非动脉瘤性蛛网膜下腔出血患者
J Neurosci Nurs. 2015 Oct;47(5):E2-11. doi: 10.1097/JNN.0000000000000163.
9
Clinical Outcome and Prognostic Factors of Patients with Perimesencephalic and Nonperimesencephalic Subarachnoid Hemorrhage.经脑旁区和非经脑旁区蛛网膜下腔出血患者的临床转归和预后因素。
World Neurosurg. 2022 Sep;165:e512-e519. doi: 10.1016/j.wneu.2022.06.086. Epub 2022 Jun 24.
10
Predictors of excellent functional outcome in aneurysmal subarachnoid hemorrhage.动脉瘤性蛛网膜下腔出血功能预后良好的预测因素。
J Neurosurg. 2015 Feb;122(2):414-8. doi: 10.3171/2014.10.JNS14290. Epub 2014 Dec 12.

本文引用的文献

1
Beyond Functional Impairment: Redefining Favorable Outcome in Patients with Subarachnoid Hemorrhage.超越功能障碍:重新定义蛛网膜下腔出血患者的良好预后。
Cerebrovasc Dis. 2021;50(6):729-737. doi: 10.1159/000517242. Epub 2021 Jul 20.
2
Patient-Reported Experience Measures in Stroke Care: A Systematic Review.患者报告的卒中护理体验测量指标:系统评价。
Stroke. 2021 Jul;52(7):2432-2435. doi: 10.1161/STROKEAHA.120.034028. Epub 2021 May 10.
3
Development of a patient-reported outcome measure for patients who have recovered from a subarachnoid hemorrhage: the "questionnaire for the screening of symptoms in aneurysmal subarachnoid hemorrhage" (SOS-SAH).
开发一种用于蛛网膜下腔出血后康复患者的患者报告结局测量工具:“动脉瘤性蛛网膜下腔出血症状筛查问卷”(SOS-SAH)。
BMC Neurol. 2021 Apr 16;21(1):162. doi: 10.1186/s12883-021-02184-x.
4
Incidence and Outcome of Aneurysmal Subarachnoid Hemorrhage: The Swiss Study on Subarachnoid Hemorrhage (Swiss SOS).颅内动脉瘤性蛛网膜下腔出血的发病率和转归:瑞士蛛网膜下腔出血研究(Swiss SOS)。
Stroke. 2021 Jan;52(1):344-347. doi: 10.1161/STROKEAHA.120.029538. Epub 2020 Dec 4.
5
How do patient reported outcome measures (PROMs) support clinician-patient communication and patient care? A realist synthesis.患者报告结局测量指标(PROMs)如何支持临床医生与患者之间的沟通及患者护理?一项实在论综合分析。
J Patient Rep Outcomes. 2018 Sep 15;2:42. doi: 10.1186/s41687-018-0061-6. eCollection 2018 Dec.
6
Understanding and measuring quality of care: dealing with complexity.理解与衡量医疗质量:应对复杂性。
Bull World Health Organ. 2017 May 1;95(5):368-374. doi: 10.2471/BLT.16.179309. Epub 2017 Mar 20.
7
Stable incidence but declining case-fatality rates of subarachnoid hemorrhage in a population.某人群中蛛网膜下腔出血的发病率稳定但病死率呈下降趋势。
Neurology. 2016 Nov 22;87(21):2192-2197. doi: 10.1212/WNL.0000000000003353. Epub 2016 Oct 21.
8
Patient reported outcome measures could help transform healthcare.患者报告结局测量有助于改变医疗保健。
BMJ. 2013 Jan 28;346:f167. doi: 10.1136/bmj.f167.
9
Measuring patient-reported outcomes: moving from clinical trials into clinical practice.衡量患者报告的结局:从临床试验转向临床实践。
Med J Aust. 2008 Jul 21;189(2):93-4. doi: 10.5694/j.1326-5377.2008.tb01928.x.
10
The impact of measuring patient-reported outcomes in clinical practice: a systematic review of the literature.在临床实践中测量患者报告结局的影响:文献系统综述
Qual Life Res. 2008 Mar;17(2):179-93. doi: 10.1007/s11136-007-9295-0. Epub 2008 Jan 4.